Table 1 General characteristics of the patients
Categories | CVP ≥ 8 mmHg (n = 244) |
|---|---|
Age, years | 64 (50, 72) |
Male gender(n, %) | 154 (63.1) |
APACHEII | 20 (15, 27) |
SOFA | 12 (10, 14) |
Comorbidities (n, %) | |
 HTN | 114 (46.7) |
 DM | 64 (26.2) |
 CAD | 39 (15.9) |
 CKD | 26 (10.7) |
 COPD | 10 (4.1) |
Site of infection (n, %) | |
 Abdominal | 121 (49.6) |
 Lung | 44 (18.0) |
 Soft tissue | 15 (6.1) |
 Biliary tract | 11 (4.5) |
 UTI | 9 (3.7) |
 aOthers | 44 (18.0) |
NE infusion (n, %) | 209 (85.7) |
NE dose (μg/kg/min) | 0.4 (0.2, 0.7) |
HR (bpm) | 97 (83, 108) |
MAP (mmHg) | 85 (77, 90) |
CVP (mmHg) | 9 (9, 11) |
MV(n, %) | 222 (91.0) |
PEEP (cmH2O) | 7 (5, 8) |
Pplat (cmH2O) | 19 (16, 21) |
Fluid expansion (ml) | 3667 (2941, 4734) |
ICU stay (day) | 6 (3, 11) |
30-day mortality (n, %) | 59 (24.2) |